HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · Real-Time Price · USD
15.97
-0.03 (-0.19%)
Aug 14, 2025, 11:45 AM - Market open
Revenue by Product
Fiscal year is January - December.
Year Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | NaN - NaN |
---|---|---|---|---|---|---|
Oncology/Immunology - Research and Development | 2.85B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Oncology/Immunology - Research and Development Growth | 829.49% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Ventures | 2.42B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Ventures Growth | 17.81% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Oncology/Immunology - Marketed Products | 1.29B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Oncology/Immunology - Marketed Products Growth | 31.68% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Commercial Platform - Prescription Drugs | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Commercial Platform - Prescription Drugs Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Commercial Platform - Consumer Health | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Commercial Platform - Consumer Health Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Innovation Platform - Drug Research & Development | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Innovation Platform - Drug Research & Development Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Year Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | NaN - NaN |
---|---|---|---|---|---|---|
China | 3.80B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China Growth | 13.69% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States and Others | 2.76B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Hong Kong | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Hong Kong Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|